Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
26.80    -0.05 (-0.19%)
Bid:
26.25
Ask:
27.00
Spread: 0.75 (2.857%)
Market Cap: £79.14m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Director/PDMR Shareholding

11 Mar 2026 07:00

RNS Number : 1354W
Severfield PLC
11 March 2026
 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

Due to an administrative oversight, this notification, relating to a transaction on 7 January 2026, is being released at a later date.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Paul McNerney

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Severfield plc

b)

LEI

21380025AWPR781CY104

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2.5p

 

GB00B27YGJ97

 

b)

Nature of the transaction

Grant of an award under the Company's Performance Share Plan as a conditional award of shares. Subject to performance conditions and continued service, the award normally vests in June 2028.

The performance conditions are weighted as follows:

· 50% is based on an EPS target for the year ending 31 March 2028 of 5.8 pence (threshold performance - 12.5% vests) to 7.9 pence (maximum performance - 50% vests) with linear interpolation in between. This represents a PBT range of £22m to £30m.

· 20% is based on an ROCE target for the year ending 31 March 2028 of 10% (threshold performance -5% vests) to 13% (maximum performance - 20% vests) with linear interpolation in between.

· 30% is based on 5 key transformational objectives relating to improved market prioritisation, manufacturing and project delivery. Certain details of the transformation programme metrics are commercially sensitive and will therefore be disclosed retrospectively at the point of vesting.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 Nil

1,843,972

d)

Aggregated information

-

Aggregated volume

-

Price

Not applicable-single transaction

e)

Date of the transaction

7/1/26

f)

Place of the transaction

Outside a trading venue

 

 

Name of Company Official responsible for making notification: 

Mark Sanderson, Company Secretary

Contact details: 01845 577896

Severfield plc

Severs House

Dalton Airfield Industrial Estate

Thirsk

North Yorkshire

YO7 3JN

7th January 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHJMMTTMTABTMF
Date   Source Headline
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20221:14 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:19 amRNSNOTICE OF CHANGE TO DIRECTOR DETAILS
22nd Nov 20227:30 amRNSProgressive publishes new research
22nd Nov 20227:00 amRNSInterim Results
9th Nov 20224:41 pmRNSSecond Price Monitoring Extn
9th Nov 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20227:39 amRNSProgressive publishes new research
17th Oct 20224:36 pmRNSPrice Monitoring Extension
13th Oct 20228:27 amRNSDirector/PDMR Shareholding
3rd Oct 202210:16 amRNSDirectorate Change - Replacement
3rd Oct 20227:00 amRNSDirectorate Change
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 202211:44 amRNSResult of AGM
8th Sep 20227:31 amRNSProgressive publishes new research
8th Sep 20227:00 amRNSTrading Statement
8th Aug 202212:00 pmRNSNotice of Annual General Meeting and Annual Report
27th Jul 20222:31 pmRNSHolding(s) in Company
25th Jul 20229:40 amRNSDirector/PDMR Shareholding
13th Jul 202211:26 amRNSDirector/PDMR Shareholding
29th Jun 202212:01 pmRNSDirector/PDMR Shareholding
29th Jun 202212:00 pmRNSDirector/PDMR Shareholding
17th Jun 202210:36 amRNSDirector/PDMR Shareholding
15th Jun 20227:29 amRNSProgressive publishes new research
15th Jun 20227:00 amRNSResults for the year ended 26 March 2022
1st Jun 20229:47 amRNSTotal Voting Rights and Share Capital Update
3rd May 20221:12 pmRNSVoting Rights and Share Capital Update
25th Apr 20225:24 pmRNSHolding(s) in Company
20th Apr 20229:38 amRNSProgressive publishes new research
20th Apr 20227:00 amRNSPre-close Trading Update
5th Apr 20224:22 pmRNSHolding(s) in Company
1st Apr 20222:23 pmRNSVoting Rights and Share Capital Update
18th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSAppointment of Joint Broker
10th Mar 20221:59 pmRNSReplacement - Holding(s) in Company
10th Mar 20227:35 amRNSNotice of Change to Director Details
7th Mar 20226:12 pmRNSHolding(s) in Company
2nd Mar 20224:43 pmRNSVoting Rights and Share Capital Update
2nd Mar 20224:40 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:16 amRNSVoting Rights and Share Capital Update
5th Jan 202211:31 amRNSVoting Rights and Share Capital Update
20th Dec 20214:31 pmRNSCompletion of successful refinancing
9th Dec 20217:59 amRNSNotice of Change to Director Details
7th Dec 20213:31 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:17 pmRNSIssue of Ordinary Shares
23rd Nov 20217:57 amRNSProgressive publishes new research
23rd Nov 20217:01 amRNSInterim Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.